New drug trial hopes to tame rare Syndrome's relentless hunger
Disease control
Recruiting now
This early-stage trial tests an experimental drug called CSTI-500 in 12 people aged 13 to 50 with Prader-Willi syndrome, a genetic condition that causes constant hunger and behavioral issues. The study aims to see if the drug is safe and can reduce excessive eating behaviors. Par…
Phase: PHASE2 • Sponsor: ConSynance Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC